ArticleAntimicrobial agents and chemotherapy2017
Some Synonymous and Nonsynonymous
Open access · hybridAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 35 citations in OpenAlex.
- Multidrug-Resistant Urinary Tract Infections in Pregnant Patients and Their Association with Adverse Pregnancy Outcomes-A Retrospective Study.Journal of clinical medicine · 2024Article
- Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.The Lancet. Infectious diseases · 2023Review
- Direct detection of drug-resistantFrontiers in public health · 2023Article
- In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis.Scientific reports · 2022Article
- Predicting antibiotic resistance in complex protein targets using alchemical free energy methods.Journal of computational chemistry · 2022Article
- Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.BMC infectious diseases · 2022Article
- Article
- Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.Antimicrobial agents and chemotherapy · 2021Article
- On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex.Journal of clinical microbiology · 2021Article
- Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?The European respiratory journal · 2021Article
- Article
- Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.Genome medicine · 2020Article
- Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.Pathogens (Basel, Switzerland) · 2019Article
- Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.Nature reviews. Microbiology · 2019Review
- Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review.Frontiers in microbiology · 2019Review
- Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".Antimicrobial agents and chemotherapy · 2018Article
- Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance inInfection and drug resistance · 2018Article
- Evaluation of Genotype MTBDRFrontiers in microbiology · 2018Article
- Article
- A standardised method for interpreting the association between mutations and phenotypic drug resistance inThe European respiratory journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 13 institutions in 6 countries.
Adebisi AjileyePublic Health England West Midlands Public Health Laboratory, Heartlands Hospital, Birmingham, United Kingdom.
Nataly AlvarezBacteriology and Mycobacteria Unit, Corporación Para Investigaciones Biológicas, Medellín, Colombia.
Matthias MerkerDivision of Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Timothy M WalkerNuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Suriya AkterMycobacteriology Unit, Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium.
Kerstin BrownPublic Health England West Midlands Public Health Laboratory, Heartlands Hospital, Birmingham, United Kingdom.
Danesh MoradigaravandWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Thomas SchönDepartment of Clinical and Experimental Medicine, Division of Medical Microbiology, Linköping University, Linköping, Sweden.
Sönke AndresDivision of Mycobacteriology, National Tuberculosis Reference Laboratory, Research Center Borstel, Borstel, Germany.
Viola SchleusenerDivision of Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Shaheed V OmarCentre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Francesc CollLondon School of Hygiene & Tropical Medicine, London, United Kingdom.
Hairong HuangNational Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Roland DielInstitute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Nazir IsmailCentre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Julian ParkhillWellcome Trust Sanger Institute, Hinxton, United Kingdom.ORCID 0000-0002-7069-5958
Bouke C de JongMycobacteriology Unit, Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium.
Tim E A PetoNuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Derrick W CrookNuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Stefan NiemannDivision of Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Jaime RobledoBacteriology and Mycobacteria Unit, Corporación Para Investigaciones Biológicas, Medellín, Colombia.
E Grace SmithPublic Health England West Midlands Public Health Laboratory, Heartlands Hospital, Birmingham, United Kingdom.
Sharon J PeacockWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Claudio U KöserDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom cuk21@cam.ac.uk.ORCID 0000-0002-0232-846X
John Radcliffe Hospital · GBPublic Health England · GBGerman Center for Infection Research · DEInstituut voor Tropische Geneeskunde · BENational Institute for Communicable DiseasesResearch Center Borstel - Leibniz Lung Center · DEUniversidad Pontificia Bolivariana · COUniversity of Cambridge · GBWellcome Sanger Institute · GBCapital Medical University · CNLinköping University · SELondon School of Hygiene & Tropical Medicine · GBUniversity Hospital Schleswig-Holstein · DE
Funding
Department of HealthWellcome TrustWellcome Trust 201344/Z/16/Z
Abstract
In this study, using the Hain GenoType MTBDR
Indexed as
MutationAntitubercular AgentsBiological AssayDNA GyraseDrug Resistance, Multiple, BacterialFalse Positive ReactionsFluoroquinolonesGene ExpressionHumansMycobacterium tuberculosisOligonucleotide ProbesPhylogenyTuberculosis, Multidrug-ResistantAntitubercular AgentsDNA GyraseFluoroquinolonesOligonucleotide ProbesfluoroquinolonesHain GenoType MTBDRslMycobacterium tuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.